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Abstract
Background Little is known about immediate implant placement in head and neck cancer patients. We studied implant survival
and functional outcomes of overdentures fabricated on implants placed immediately after removal of the lower dentition during
ablative surgery or preceding primary radiotherapy (RT).
Methods Inclusion criteria were primary head and neck cancer, dentate lower jaw, and indication for removal of remaining teeth.
Two implants to support a mandibular overdenture were placed immediately after extraction of the dentition during ablative
surgery, or prior to starting primary radiotherapy. Standardized questionnaires and clinical assessments were conducted (median
follow-up 18.5 months, IQR 13.3).
Results Fifty-eight implants were placed in 29 patients. Four implants were lost (implant survival rate 93.1%). In 9 patients, no
functional overdenture could be made. All patients were satisfied with their dentures.
Conclusions Combining dental implant placement with removal of remaining teeth preceding head neck oncology treatment
results in a favorable treatment outcome.
Keywords Dental implants . Head and neck cancer . Tooth extraction . Radiation therapy . Patient satisfaction
Introduction
In patients with malignancies in the oral cavity, oral foci (car-
ies profunda, periodontal disease, presence of periapical pa-
thology) are frequently encountered during pre-radiation den-
tal screening [1–3]. Detection and elimination of these oral
foci before starting treatment are needed for patients in need
of radiation therapy to prevent post-radiation oral sequelae.
For some patients, elimination of oral foci implies removal
of all remaining teeth during tumor resection. In patients
who will undergo primary radiotherapy, the teeth are usually
removed 2–3 weeks before starting radiotherapy [4]. Patients
are often left with a strongly reduced oral function due to the
changed anatomical situation after surgery.When ablative sur-
gery is followed by radiotherapy, oral function is additionally
compromised due to reduced salivary secretion, reduced
chewing, swallowing, and radiotherapy-induced trismus.
Fabricating a functional conventional denture in the lower
jaw is challenging and sometimes even impossible [5, 6].
Dental implant placement in patients with oral cancer results
in improvement of oral function after oncological treatment
[7–9]. Lower implant survival rates have been associated with
radiotherapy; however, with appropriate perioperative mea-
surements and strict monitoring, irradiated patients can also
benefit from dental implant placement [10–15].
Several options exist regarding timing of implant place-
ment in oncology patients. Implants can be inserted after on-
cologic treatment is completed. When necessary, extraction of
the remaining dentition is carried out during ablative surgery,
and implants are placed in a second surgery when the surgical
defect is fully healed and patients have completed postopera-
tive radiotherapy. A possible benefit of this method is that
proper implant planning and positioning can be achieved to
facilitate the implant supported overdenture. Also, when post-
poning the decision to start implant treatment until after onco-
logic surgery or radiotherapy, the clinician has the opportunity
Electronic supplementary material The online version of this article
(https://doi.org/10.1007/s00520-020-05431-y) contains supplementary
material, which is available to authorized users.
* Jamie M. Alberga
j.m.alberga@umcg.nl
1 Department of Oral and Maxillofacial Surgery, University of
Groningen, University Medical Center Groningen, Groningen, the
Netherlands
Supportive Care in Cancer
https://doi.org/10.1007/s00520-020-05431-y
to only select those patients with severe functional problems
who are presumed to benefit from an implant-supported
overdenture. In this manner, no implants are placed in patient
who will not use them or who will be deceased before starting
the prosthetic rehabilitation process. This could be of value
from a cost-effectiveness point of view. A major disadvantage
is the need for additional surgical procedures. Oral cancer
patients have shown to decline additional implant surgery af-
ter finishing the oncologic treatment, even when significant
benefits were to be gained from the treatment. This issue is
probably related to treatment exhaustion [16]. Another disad-
vantage when treating patients after oncologic therapy is that
patients who have received radiotherapy may need antibiotic
prophylaxis and/or a course of pre-treatment hyperbaric oxy-
gen therapy in order to prevent osteoradionecrosis.
Alternatively, implants can be placed during ablative sur-
gery. Combining implant placement and tumor surgery has
certain benefits: implants are not placed in irradiated bone,
patients do not need additional surgery with antibiotics or
long-term hyperbaric oxygen therapy, and oral rehabilitation
starts earlier, resulting in an increased quality of life [17].
Possible disadvantages of implant insertion during ablative
surgery are improper implant positioning especially in patients
with large defects, difficulties in acquiring sufficient
keratinized mucosa around the implants, not using placed im-
plants due to tumor recurrence, and patients refusing abutment
connection surgery. In a longitudinal, prospective clinical trial
on implant placement during ablative surgery refusal of abut-
ment, connection surgery occurred in 3 out of 50 included
patients [17].
Current research on implant insertion during ablative sur-
gery has mainly focused on patients who were edentulous at
the time of diagnosis or had their teeth extracted before tumor
surgery in a separate procedure [8, 18–21]. These patients
show high overall implant survival rates (> 90%) and are gen-
erally satisfied with the function of their implant supported
overdenture [8, 18–22]. For patients with a remaining denti-
tion which needs to be removed, there are three options re-
garding dental rehabilitation: (1) removal of the dentition and
fabrication of a conventional denture, (2) removal of the den-
tition during ablative surgery followed by delayed dental im-
plant placement in healed sites, or (3) immediate implant
placement after tooth extraction in fresh extraction sockets
(Supplementary Fig. 1). In healthy patients, a systematic re-
view showed that implants placed immediately after tooth
extraction are accompanied by a survival rate comparable to
implants placement in healed sites [23, 24]. Even though there
are studies claiming that immediate implant placement leads
to a decrease in survival rates [25], the use of immediate im-
plant therapy in specific populations, as in this study, requires
consideration because of the potential benefits like a decrease
in prosthetic rehabilitation time and fewer surgical procedures,
to be gained from the therapy. In addition, dental loss has a
negative impact on patients’ quality of life which further em-
phasizes the importance of adequate dental rehabilitation
[26–28]. Therefore, the aim of this study was to assess perfor-
mance of implants placed immediately after teeth extraction in
the mandible during ablative surgery or preceding primary
radiotherapy. Also, the study aims to describe oral function
and denture satisfaction after immediate implant placement in
patients with head and neck cancer.
Material and methods
Patients
All consecutive patients with a malignancy in the head and
neck region referred to the head and neck center of the
University Medical Center Groningen between 2014 and
2017 were screened to be included in this study. The inclusion
criteria were primary tumor in the head and neck region, den-
tate lower jaw, and an indication for removal of the remaining
dentition due to the presence of dental foci.
The oncologic treatment consisted of ablative surgery
(when needed followed by postoperative radiotherapy) or pri-
mary radiotherapy (RT). Patients eligible for surgical removal
of the tumor had their teeth removed during ablative surgery.
These patients were offered either primary immediate mandib-
ular implant placement (during ablative surgery), delayed
mandibular implant placement (after completion of oncologic
treatment), or no implant placement. For patients planned to
receive primary radiotherapy, extraction of the remaining den-
tition followed by immediate mandibular implant placement
at least 2 weeks before starting radiotherapy, delayed implant
placement after radiotherapy or no implant placement was
offered. All patients preferred primary immediate implant
mandibular placement and informed consent was obtained.
It was concluded by the Medical Ethical committee of the
University Medical Center Groningen that this study was not
subject to the Medical Research Involving Human Subjects
Act (Number M19.234574).
After extraction of the remaining dentition, the extraction
sockets were thoroughly cleaned, the height of the lower al-
veolar ridge was reduced, and care was taken to round off the
sharp bone edges. The implant regions were prepared, and
implants were placed in the native bone during ablative sur-
gery with good primary stability of 45Ncm (Supplementary
Fig. 1). Two dental implants (Brånemark Mk III TiUnite RP,
Nobel Biocare, Gothenburg, Sweden) were placed in the
interforaminal area in a two-stage procedure by the same sur-
geon (GMR). All implants were placed with antibiotic pro-
phylaxis (amoxicillin/clavulanic acid 1000/200 mg i.v.). An
osseointegration period of 3 months was considered for pa-
tients receiving only surgery and patients receiving only ra-
diotherapy. In patients subjected to surgery followed by
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postoperative radiotherapy (starting 6 weeks after surgery),
abutment connection surgery was postponed until after
finishing the radiotherapy treatment, and the short-term side
effects of radiotherapy had subsided. Abutment connection
surgery was carried out under local anesthesia. Two weeks
after abutment connection surgery, prosthodontic rehabilita-
tion was started. An implant-supported overdenture was made
by a maxillofacial prosthodontist. The mandibular
overdentures were supported by a bar-clip construction. For
all patients receiving radiotherapy, the cumulative dose at the
implant locations was attained from the radiation plan provid-
ed by the radiotherapist.
Clinical assessments
All patients were on a standardized recall schedule. After
placement of the overdenture, patients were examined
half-yearly by a prosthodontist. Clinical parameters, im-
plant loss, and postoperative complications (inflamma-
tion, wound dehiscence, sequestration) were prospectively
collected from the time of implant placement until final
assessment in 2018.
During intraoral examination, the following clinical param-
eters were assessed:
& Plaque index assessed at four sites per implant (mesial,
buccal, distal, lingual) using the modified plaque index
[29].
& Bleeding index: assessed at four sites per implant (mesial,
buccal, distal, and lingual) using the modified sulcus
bleeding index [29].
& Gingiva index: Measured on a 4-point scale from 0 to 3:
0 = no visible inflammation, 1 =mild inflammation (mod-
erate redness, mild swelling), 2 = moderate inflammation
(moderate redness), 3 = severe inflammation (severe red-
ness, swelling ulceration) [30].
& Probing pocket depth: measured to the nearest 1 mm using
a manual periodontal probe (Williams Color-Coded
Probe; Hu-Friedy, Chicago, ILUSA) at the mesial, buccal,
distal, and lingual aspects of the implants. Subsequently,
the largest pocket depth for each implant was included for
analysis.
Radiographic analysis
At least 2 panoramic radiographs of each patient were
made, one directly after implant insertion and one dur-
ing final assessment. The change in marginal bone loss
(in millimeters) in relation to the implant shoulder was
calculated (Supplementary Fig. 1).
Oral health impact, functional assessment,
and patient satisfaction
Oral function and patient satisfaction were assessed when the
denture had been in situ for a period of at least 6 months.
Overall patient satisfaction was expressed on a 10-point rating
scale ranging from very dissatisfied (1) to very satisfied (10).
Denture satisfaction was specifically measured by a validated
questionnaire on denture satisfaction consisting of 8 items
focusing on upper and lower dentures, and on specific features
such as esthetics, retention, and functional comfort [31].
Answers are given on a 5-point rating scale ranging from very
satisfied (0) to very dissatisfied (4). Regarding the oral func-
tion, patients were asked to fill in a 9-item questionnaire on
their ability to chew different kinds of food [32]. The Oral
Health Impact Profile in short-form (OHIP-14) was used to
assess the physical, psychological, and social impact of oral
disease [33]. Patients were asked to answer questions about
the frequency of pain, functional limitations, psychological
discomfort, and social disability. Responses are made on a
5-point scale coded from never (0) to very often (4).
Data analysis
Data analysis was performed using the Statistical Package for
Social Sciences (version 23, SPSS Inc., Chicago, IL, USA).
Depending on the distribution of the data, results are either
expressed as mean ± standard deviation (s.d.) or median (in-
terquartile range; IQR). When comparing data of ratio level
between radiated and irradiated patients, the independent-
samples t test was used. Between-group comparisons for or-
dinal data were calculated with the Mann–Whitney U test.




Twenty-nine patients, 15 men and 14 women, participated in
this study (mean age 63.4 ± 11.1 years; range 31–81 years).
Patient demographics and treatment intervals of irradiated and
non-irradiated patients are presented in Tables 1 and 2. 79.3%
of the patients smoked at the time of the intake. The reasons
for removal of the dentition were severe periodontal disease,
non-restorable caries profunda, and periapical infections.
Eight patients (27.6%) were subjected to primary radio-
therapy with a dose of 70 Gy at the tumor site. The average
radiation dose at the implant site for these patients was
32.9 ± 4.8 Gy (range 27–40Gy). Thirteen patients
(65.5%) were treated with postoperative radiotherapy with
a mean radiation dose at the tumor site of 62.4 ± 7.4 Gy
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(range 46–70 Gy) and 41.1 ± 21.5 Gy (range 2.1–64.6 Gy)
at the implant region. Eight patients were treated by sur-
gery only. One patient treated with postoperative radiother-
apy developed osteoradionecrosis near the implant region
which healed after a sequestrectomy under local
anesthesia.
During the first 2 weeks postoperatively, there were no
problems with wound healing related to the implant proce-
dure. Four implants in three patients were lost during
follow-up which results in an overall implant survival rate
of 93.1%. Implant loss was not associated with smoking.
The implants that were lost had been in situ for a mean
period of 17.3 ± 15.4 months (range 7–35 months). All
implant losses occurred in irradiated patients (primary RT
n = 2; postoperative RT n = 1) who received a radiation
dose above 40 Gy at the implant site. This leads to implant
survival rates of 90.5% and 100%, respectively, in irradi-
ated and non-irradiated patients. The primary tumor in the
patients with implant loss was located in the oropharynx
(n = 2; T2-T3 tumors) or floor of mouth (n = 1; T4 tumor).
One patient received a new implant 3 months after the old
implant was removed. The new implant was placed under
local anesthesia with antibiotic prophylaxis. The second
patient lost both implants and continued to wear a conven-
tional denture. The third patient lost one implant and con-
tinued to wear an implant-supported overdenture.
Table 1 Patient characteristics
regarding age at implant
placement, gender, diagnosis, and
type of reconstruction of the soft




Gender Tumor Stage Type of reconstruction
1 65 Male Maxillary sinus T3N0 Primary closure
2 81 Female Tongue T1N1 Split thickness skin graft
3 62 Male Oropharynx T3N2c N/A (primary RT)
4 61 Male Mandibular gingiva T4N2b Free vascularized flap
5 63 Male Oropharynx T4aN2b N/A (primary RT)
6 73 Female Buccal mucosa T2N0 Free vascularized flap
7 31 Male Lower lip T2N0 Free vascularized flap
(after multiple
re-excisions)
8 51 Male Supraglottic larynx T4N3 N/A (primary RT)
9 66 Female Floor of the mouth T4N1 Split thickness skin graft
10 76 Female Mandibular gingiva T1N0 Primary closure
11 57 Female Mandibular gingiva T4N0 Regional flap
12 56 Male Oropharynx T4apN3 N/A (primary RT)
13 62 Female Floor of the mouth T4N2c Split thickness skin graft
14 71 Female Floor of the mouth T1N0 Local flap
15 47 Male Mandibular gingiva T4aN0 Free vascularized flap
16 58 Male Oropharynx T2cN2b N/A (primary RT)
17 74 Female Mandibular gingiva T4N0 Free vascularized flap
18 62 Female Tongue T2N0 Primary closure
19 56 Male Tongue T3N2c Split thickness skin graft
20 66 Male Floor of the mouth T1N0 Split thickness skin graft
21 80 Male Supraglottic larynx T3cN2b N/A (primary RT)
22 69 Female Mandibular gingiva T1N0 Regional flap
23 49 Female Oropharynx T4N2c N/A (primary RT)
24 59 Male Floor of the mouth T1N0 Local flap
25 60 Female Carcinoma ex pleiomorphic
adenoma of the
submandibular gland
T3N0 N/A (removal of the
gland)
26 71 Male Floor of the mouth T1N0 Split thickness skin graft
27 60 Female Maxilla T4N0 Free vascularized flap
28 83 Male Tongue T1N0 Primary closure
29 68 Female Oropharynx T4bN2c N/A (primary RT)
N/A, not applicable; RT, radiotherapy
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In 9 patients, no functional implant-retained overdenture
could bemade because of tumor recurrence in the implant region
ormetastatic tumor growth (n = 5), implant loss (n= 2), or severe
pain in the implant area (n= 1). One patient did not show up for
further follow-up (Supplementary Fig. 2). The remaining 20 pa-
tients received implant-retained mandibular overdentures of
which 13 had undergone radiotherapy. After overdenture place-
ment, seven patients had to be excluded for further assessment,
due to refusing further follow-up at the prosthodontist and onco-
logic surgeon after receiving the overdenture (n = 3), tumor re-
currence or death (n= 2), dehiscence occurrence around the re-
construction plate in such manner that the patient was not
allowed to wear the fabricated overdenture (n = 1), and implant
loss (n= 1). Ultimately, 13 patients received oral function ques-
tionnaires. Of these 13 patients, 8 patients had received
radiotherapy.
Clinical and radiographic analysis
The plaque and bleeding scores around the implants were con-
sidered low for all patients in the study group. Mean probing
pocket depth was 2.3 ± 0.4 mm with a mean marginal bone loss
around the implants of 1 ± 0.7 mm. Peri-implant bone loss was
greater (but not statistically significant) in irradiated patients than
in patients who were treated by surgery only (respectively,
1.5 mm and 0.9 mm). There were no clinically and statistically
significant differences between irradiated and non-irradiated pa-
tient with the exception of the bleeding index (Table 3).
Oral health impact, functional assessment,
and patient satisfaction
Results of the OHIP-14, total chewing ability, and denture
satisfaction are presented in Table 4. A higher score for
denture satisfaction and chew function indicates a less satis-
fied patient and worse chew function. A higher OHIP-14 score
indicates a higher physical, psychological, and social impact
of the oral disease. The results show reasonably satisfied pa-
tients and good oral function for all three types of food. No
statistically significant differences could be found in chewing
ability and satisfaction rates between irradiated and non-
irradiated patients (Table 5).
Discussion
This study aimed to assess the treatment outcomes of mandib-
ular implants placed immediately after removal of the denti-
tion in head and neck cancer patients. The results showed a
high implant survival rate for non-irradiated patients and a
reduced survival rate in irradiated patients. The implant sur-
vival rates are comparable to the edentulous patients in previ-
ous studies [17, 19, 20].
A history of radiation therapy is not considered a contrain-
dication for implant placement as long as strict monitoring is
provided to prevent complications [12]. Previous studies on
implant placement in irradiated patients do not regard imme-
diate implant placement, making a comparison between our
study and previously published studies not entirely reliable
[10–15]. But as all implant losses in our study occurred in
irradiated patients, it can be stated that radiotherapy also has
a negative effect on survival of immediately placed implants.
Due to the small sample size in the current study, no reliable
conclusion could be drawn on implant survival rates or the
proportion of unused implants in relation to tumor stage or
tumor location. The optimal time between implant placement
and start of radiotherapy is still in need of further research.
One could argue that the osseointegration of implants placed
Table 3 Results of periodontal
indices around the implants
between irradiated patients and
non-irradiated patients
Surgery and postoperative RT Only surgery
Median Mean s.d. Median Mean s.d. p value
Bleeding index (0–3) 0 0.4 0.7 1 1.2 0.8 0.04
Plaque index (0–3) 1 0.8 0.7 1 0.8 0.4 0.80
Pocket depth (mm) NA 2.2 0.4 NA 2.5 0.3 0.18
Marginal bone loss (mm) NA 2 0.6 NA 1 0.9 0.17
Table 2 Treatment intervals of






Time between implant placement and second stage surgery 5.5 (2.7) 3.9 (1.3)
Time between implant placement and prosthesis placement 8.3 (3.1) 7.4 (3.9)
Time between implant placement and data collection 16.3 (9.4) 21.7 (8.9)
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pre-radiation therapy has already largely taken place before
the bone is compromised by radiotherapy [34], but it is known
that late effects of radiotherapy continue years after the initial
treatment is finished. The implants in our study were on aver-
age inserted 5.3 weeks before starting postoperative radiother-
apy and 2.9 weeks before starting primary radiotherapy. Thus,
the implants were not in the process of osseointegration when
radiotherapy was started, and this could have played a role in
the implant loss in the irradiated patients. It is, however, from
an oncologic treatment perspective, not preferable to further
delay the start of radiation therapy. All irradiated patients in
the current study received intensity-modulated radiation ther-
apy (IMRT). A tendency towards more bone loss in irradiated
patients than in those without radiotherapy was seen. This
finding is comparable to the findings of Ernst et al. [35]. In a
recent study of Papi et al. [36], the type of radiotherapy (3D
conform radiotherapy versus IMRT) does not seem to effect
the amount of peri-implant bone loss.
One of the advantages of primary implant placement is the
early prosthodontic rehabilitation in head and neck oncology
patients as confirmed by the studies of Wetzels et al. [8] and
Mizbah et al. [21]. In an earlier study of Korfage et al. [37],
non-irradiated patients received their overdenture after
6 months, and irradiated patients received their overdenture
after 11 months. This difference in loading time is due to the
minimal time-span of 6 months applied for irradiated patients
between the end of radiotherapy and abutment connection
surgery. The rationale behind this additional healing period
is that implants are given some extra time for osseointegration
and that the radiation effects on the soft-tissue will have sub-
sided. Schoen et al. [16] have already questioned whether the
additional 6 months is really necessary because most of the
osseointegration takes place during the first 6 weeks after
placement. In our study, abutment connection surgery in irra-
diated patients took place as soon as the treatments at the
department of radiotherapy were completed and the short-
term side effects of radiotherapy had subsided. This probably
resulted in a shortening of the time until overdenture place-
ment (8.3 months).
A possible disadvantage of implant placement during ab-
lative surgery is improper positioning of implants, due to an
altered anatomical situation or intermaxillary relationship,
e.g., after mandibular continuity resections. In our study, all
primary implants could be placed in a proper position, even in
patients with a tumor located more ventral in the floor of the
mouth. In those cases, it is often difficult to acquire enough
keratinized mucosa around the implants and sometimes a sec-
ondary mucosa graft might be necessary. This was not needed
in the current study.
Satisfaction rates and oral function do not seem to be influ-
enced by radiotherapy in the current study. Overall, it could be
stated that the results are comparable to previously edentulous
patients [20]. The results in our study are to be considered as
short-term results but it is expected that the oral function will
be rather stable, as this is also the case in an earlier study from
our group [7]. From the results of the OHIP-14 questionnaire
(Table 5), non-irradiated patients seem to experience more
physical, psychological, and social impact of their oral func-
tioning than the irradiated patients. This is striking because
irradiated patients are expected to experience a larger oral
health-related impact due to the effects of radiotherapy.
When examining the individual results of the patients, it was
revealed that the higher OHIP-14 score in non-irradiated pa-
tients in our study is caused by one patient being particularly
dissatisfied, therefore causing a distortion in the results be-
cause of the low number of included patients.
Another known disadvantage of implant placement during
ablative surgery is the risk of unused implants due to tumor
recurrence. In our study, this was the case for 5 patients. Four
of these patients presented with large (T4 stage) tumors with
regional metastases in combination with other comorbidities
like diabetes mellitus, COPD, and hypertension. The other
patient had multiple tumor recurrences which resulted in the
implants eventually not being used. Furthermore, 4 patients
(13.7%) refused further follow-up, 3 of these 4 patients after
having received the implant-supported denture. These patients
also declined further oncological follow-up despite efforts
with regard to the need for regular follow-up. Numbers on
head and neck cancer patients declining follow-up for their
Table 4 Patient satisfaction, functional assessment and oral health
impact
Mean (s.d.)
Overall satisfaction [0–10]* 8.6 (0.9)
Total denture satisfaction score [8–40] 12.6 (3.6)
Chew function score [0–18]a
Soft food 0.0 (0.1)
Tough food 0.2 (0.3)
Hard food 0.9 (0.9)
OHIP-14 total 5.8 (5.7)
*Range 0–10: 0 = very dissatisfied, 10 = very satisfied
a Range 0–2: scale 0 = good, 1 =moderate, 2 = bad







Overall satisfaction [0–10] 9 (0.9) 8 (0.7) 0.08
Denture satisfaction [8–40] 10.8 (3.4) 14.8 (2.8) 0.10
Chew function [0–18] 3.2 (3.0) 3.2 (3.9) 0.93
OHIP-14 total 3.8 (3.8) 8.2 (6.9) 0.27
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implant-supported overdenture are unknown, but a study by
Toljanic et al. [38] on dental follow-up of irradiated head and
neck cancer patients stated that dental follow-up compliance is
an issue in this population.
The question raises whether placing implants prior to ra-
diotherapy or during ablative surgery is cost-effective. In the
Netherlands, the costs of implant rehabilitation in head and
neck cancer patients are covered by the insurance which
makes primary immediate implant placement an actual treat-
ment option. A study of Wetzels et al. [39] on cost-
effectiveness stated that individual costs of implant placement
during ablative surgery have shown to be lower when com-
pared to postponed placement, but that factors as oncological
prognosis and overall life expectancy must be taken into ac-
count when considering placing implants during ablative sur-
gery. The same conditions should apply for immediate implant
placement.
Although this is the first study to report solely on immedi-
ate implant placement in head and neck cancer patients, there
are certain limitations. A drawback is the low number of pa-
tients and the rather high fall-out rate. Regarding the method
of measuring the marginal bone loss, it would be preferable to
use standardized intra-oral dental radiographs. However, clin-
ical experience with oral cancer teaches that in anatomically
altered patients, there is often no possibility for taking stan-
dardized intra-oral radiographs with individual devices, and
panoramic radiographs are the only option for routine follow-
up. Moreover, for evaluation of bone around implants, pano-
ramic radiographs are widely used and accepted, despite that
they distort images, superimpose bony structures of the spine,
and lack sharpness [40]. This should be taken into account
when interpreting these results. Recommendations for further
research in this field of work include identifying possible pre-
dictive factors for implant survival and setting up a treatment
algorithm for clinicians.
Despite the limitations of the study, immediate primary
implant placement is a viable treatment option and should be
offered to head and neck cancer patients because of the earlier
mentioned benefits to be gained.
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